NTI will soon double in shareprice!, page-54

Thanks for your post djwally - you put things much more succinctly than I do.

I am going to incorporate what you said into the questions I put to NTI management so it adds value and doesn't just look to get them to repeat things that they have already said.

I really like your points about:

1) Building awareness - The fact that well credentialed medical specialists will be utilised to recommend/ prescribe Mente autism devices not only disempowers the silly conspiracy theorists but creates authority for the Mente autism 'in-home' device. I imagine this will additionally garner a lot of media attention. We will have not only have further studies to prove Mente works along with parents who give qualitative reports noting improved child behavior but we will also have a legion of doctors prescribing NTI's Mente device.

2) Cost of unit - I agree with your point - if you could pay $2k to take 20-30% of the edge off of the behavioral symptoms of your child's autism - who wouldn't?!

3) In-home use - There is so much added value by utilising neurofeedback therapy in-home as compared to in a strange clinic with strangers. It makes the Mente autism device have such a large competitive advantage over what is currently offered in a clinic.

4) Market realisation - NTI's Mente autism in-home device is going to hit the market in the face and those who missed out are going to be sitting there scratching their head! Double Blind results, Training of doctor milestones, UK distribution agreement, penetration into new countries will all create the market announcements that drive share price!

Anyhow I am getting excited - I will continue to work on my questions to NTI - thanks again djwally.